221 related articles for article (PubMed ID: 23806095)
1. The role of IL-6 in the radiation response of prostate cancer.
Wu CT; Chen MF; Chen WC; Hsieh CC
Radiat Oncol; 2013 Jun; 8():159. PubMed ID: 23806095
[TBL] [Abstract][Full Text] [Related]
2. Significance of IL-6 in the transition of hormone-resistant prostate cancer and the induction of myeloid-derived suppressor cells.
Wu CT; Hsieh CC; Lin CC; Chen WC; Hong JH; Chen MF
J Mol Med (Berl); 2012 Nov; 90(11):1343-55. PubMed ID: 22660275
[TBL] [Abstract][Full Text] [Related]
3. TGF-β1 mediates the radiation response of prostate cancer.
Wu CT; Hsieh CC; Yen TC; Chen WC; Chen MF
J Mol Med (Berl); 2015 Jan; 93(1):73-82. PubMed ID: 25228112
[TBL] [Abstract][Full Text] [Related]
4. Role of interleukin-6 in the radiation response of liver tumors.
Chen MF; Hsieh CC; Chen WC; Lai CH
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e621-30. PubMed ID: 22975618
[TBL] [Abstract][Full Text] [Related]
5. The radiation response of hormone-resistant prostate cancer induced by long-term hormone therapy.
Wu CT; Chen WC; Liao SK; Hsu CL; Lee KD; Chen MF
Endocr Relat Cancer; 2007 Sep; 14(3):633-43. PubMed ID: 17914094
[TBL] [Abstract][Full Text] [Related]
6. Loss of MyD88 leads to more aggressive TRAMP prostate cancer and influences tumor infiltrating lymphocytes.
Peek EM; Song W; Zhang H; Huang J; Chin AI
Prostate; 2015 Apr; 75(5):463-73. PubMed ID: 25597486
[TBL] [Abstract][Full Text] [Related]
7. IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2.
Chen X; Chen F; Ren Y; Weng G; Xu L; Xue X; Keng PC; Lee SO; Chen Y
J Cancer Res Clin Oncol; 2019 Jun; 145(6):1471-1484. PubMed ID: 31020420
[TBL] [Abstract][Full Text] [Related]
8. Role of Myeloid-Derived Suppressor Cells in High-Dose-Irradiated TRAMP-C1 Tumors: A Therapeutic Target and an Index for Assessing Tumor Microenvironment.
Fu SY; Chen FH; Wang CC; Yu CF; Chiang CS; Hong JH
Int J Radiat Oncol Biol Phys; 2021 Apr; 109(5):1547-1558. PubMed ID: 33188861
[TBL] [Abstract][Full Text] [Related]
9. A role for paracrine interleukin-6 signaling in the tumor microenvironment in prostate tumor growth.
Yu SH; Maynard JP; Vaghasia AM; De Marzo AM; Drake CG; Sfanos KS
Prostate; 2019 Feb; 79(2):215-222. PubMed ID: 30345534
[TBL] [Abstract][Full Text] [Related]
10. MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner.
Feng FY; Zhang Y; Kothari V; Evans JR; Jackson WC; Chen W; Johnson SB; Luczak C; Wang S; Hamstra DA
Neoplasia; 2016 Apr; 18(4):213-22. PubMed ID: 27108384
[TBL] [Abstract][Full Text] [Related]
11. Lack of high-dose radiation mediated prostate cancer promotion and low-dose radiation adaptive response in the TRAMP mouse model.
Lawrence MD; Ormsby RJ; Blyth BJ; Bezak E; England G; Newman MR; Tilley WD; Sykes PJ
Radiat Res; 2013 Oct; 180(4):376-88. PubMed ID: 23971516
[TBL] [Abstract][Full Text] [Related]
12. Cell death in irradiated prostate epithelial cells: role of apoptotic and clonogenic cell kill.
Bromfield GP; Meng A; Warde P; Bristow RG
Prostate Cancer Prostatic Dis; 2003; 6(1):73-85. PubMed ID: 12664070
[TBL] [Abstract][Full Text] [Related]
13. STAT5A/B Blockade Sensitizes Prostate Cancer to Radiation through Inhibition of RAD51 and DNA Repair.
Maranto C; Udhane V; Hoang DT; Gu L; Alexeev V; Malas K; Cardenas K; Brody JR; Rodeck U; Bergom C; Iczkowski KA; Jacobsohn K; See W; Schmitt SM; Nevalainen MT
Clin Cancer Res; 2018 Apr; 24(8):1917-1931. PubMed ID: 29483142
[No Abstract] [Full Text] [Related]
14. Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model.
Inoue T; Anai S; Onishi S; Miyake M; Tanaka N; Hirayama A; Fujimoto K; Hirao Y
BMC Urol; 2013 Jan; 13():1. PubMed ID: 23289871
[TBL] [Abstract][Full Text] [Related]
15. Role of vitamin D3 in tumor aggressiveness and radiation response for hepatocellular carcinoma.
Chen PT; Hsieh CC; Chen MF
Mol Carcinog; 2022 Aug; 61(8):787-796. PubMed ID: 35611989
[TBL] [Abstract][Full Text] [Related]
16. Antagonizing CD105 enhances radiation sensitivity in prostate cancer.
Madhav A; Andres A; Duong F; Mishra R; Haldar S; Liu Z; Angara B; Gottlieb R; Zumsteg ZS; Bhowmick NA
Oncogene; 2018 Aug; 37(32):4385-4397. PubMed ID: 29717261
[TBL] [Abstract][Full Text] [Related]
17. MLN8054, a small molecule inhibitor of aurora kinase a, sensitizes androgen-resistant prostate cancer to radiation.
Moretti L; Niermann K; Schleicher S; Giacalone NJ; Varki V; Kim KW; Kopsombut P; Jung DK; Lu B
Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1189-97. PubMed ID: 21514073
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-145 Modulates Tumor Sensitivity to Radiation in Prostate Cancer.
Gong P; Zhang T; He D; Hsieh JT
Radiat Res; 2015 Dec; 184(6):630-8. PubMed ID: 26632856
[TBL] [Abstract][Full Text] [Related]
19. Significance of interleukin-6 signaling in the resistance of pharyngeal cancer to irradiation and the epidermal growth factor receptor inhibitor.
Chen CC; Chen WC; Lu CH; Wang WH; Lin PY; Lee KD; Chen MF
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1214-24. PubMed ID: 20206020
[TBL] [Abstract][Full Text] [Related]
20. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice.
Williams TM; Hassan GS; Li J; Cohen AW; Medina F; Frank PG; Pestell RG; Di Vizio D; Loda M; Lisanti MP
J Biol Chem; 2005 Jul; 280(26):25134-45. PubMed ID: 15802273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
